Clinical Trials Directory

Trials / Unknown

UnknownNCT04426487

Effect of Progesterone Therapy on Traumatic Subarachinoid Haemorrhage on Clinical Outcome and Resistive Vasculer Indices of Middle Cerebral Artery Transcranial Doppler

Effect of Progesterone Therapy in Cases With Traumatic Subarachinoid Haemorrhage on Clinical Outcome and Resistive Vasculer Indices of Middle Cerebral Artery Transcranial Doppler

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Minia University · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Traumatic subarachinoid hemorrhage is associated with serious complications related to mortality . Delayed neuronal ischemia and rebleeding are most common and serious. Progesterone can delay both .

Detailed description

Progesterone is an neurosteroid that can help integrity of blood brain barrier . Traumatic subarachinoid hemorrhage disrupts this blood brain barrier facilitating post traumatic vasospasm and neuronal ischemia. Transcranial doppler can detect cerebral vasoconstriction through resistive vasculer indices

Conditions

Interventions

TypeNameDescription
DRUGProgesteroneIntramusculer progesterone

Timeline

Start date
2020-06-20
Primary completion
2020-09-01
Completion
2020-10-30
First posted
2020-06-11
Last updated
2020-06-11

Locations

1 site across 1 country: Egypt

Regulatory

Source: ClinicalTrials.gov record NCT04426487. Inclusion in this directory is not an endorsement.

Effect of Progesterone Therapy on Traumatic Subarachinoid Haemorrhage on Clinical Outcome and Resistive Vasculer Indices (NCT04426487) · Clinical Trials Directory